Longjumeau, France 4/20/09—Horiba Jobin Yvon has acquired GenOptics, a provider of surface plasmon resonance imaging technology (SPRi) for label-free detection for an undisclosed amount. “In the coming years we will see the merging of biotechnology and microtechnology to create combinations of ultra integrated devices on a molecular scale” stated Dr. Michel Mariton, HORIBA Scientific segment […]

Farmingdale, NY 4/7/09—Misonix, a provider of ultrasonic medical device technology, has sold its Ultrasonic Laboratory business to iSonix for $3.5 million in cash. The business manufactures and markets scientific and industrial ultrasonic equipment, including the Sonicator liquid processors and cell disruptors, and generated $4.6 million in revenue in fiscal year 2008. Misonix stated that the […]

Billerica, MA 4/3/09—Bruker Advanced Supercon, a subsidiary of Bruker that provides low-temperature superconducting wire and high-temperature superconductor solutions, has acquired the research instruments portion of ACCEL Instruments GmbH from Varian Medical Systems for an undisclosed amount. Varian Medical retained ACCEL’s proton therapy business. As a result of the acquisition, Bruker has created two new subsidiaries: […]

Chicago, IL 3/9/09—Bruker BioSpin has acquired PERCH Solutions, a provider of NMR software for proton NMR prediction, spectral analysis and molecular modeling. Established in 2002 and based in Kuopio, Finland, PERCH software is part of several Bruker BioSpin NMR software products. “Many of PERCH’s market segments and applications overlap with those of our NMR small […]

St. Louis, MO 3/13/09—Sigma-Aldrich has acquired Sigal, its primary distributor in Chile, and formed Sigma-Aldrich Quimica. Terms were not disclosed. “We experienced 20% sales growth in Latin America in 2008 alone, and we believe our expanded presence in Chile, which will integrate sales, marketing and distribution, provides a solid base for consistent growth in the […]

Darmstadt, Germany 3/3/09; Boca Raton, FL 3/3/09—AppliChem GmbH and Akron Biotechnology have merged, with Akron Biotech taking over AppliChem’s operations in the Americas on March 2 and adopting the AppliChem name. AppliChem offers biochemicals and reagents. Akron Biotechnology manufactures stem cell culture products. Dr. Claudia Zylvberberg will remain president and CEO of AppliChem.

New York, NY 3/12/09—Enzo Biochem has acquired substantially all of the assets of Assay Designs for $12.2 million in cash. Assay Designs provides kits and reagents for the detection and quantification of small molecules and proteins that are important in inflammation and immunity, oxidative and cellular stress, steroid and hormone biology, cell signaling, and bioenergetics. […]